Isradipine is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Carilion Materials Management. The primary component is Isradipine.
| Product ID | 68151-1333_3d8f2a9d-e940-469a-8bda-5f7a1dc85689 |
| NDC | 68151-1333 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Isradipine |
| Generic Name | Isradipine |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2006-01-05 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA077317 |
| Labeler Name | Carilion Materials Management |
| Substance Name | ISRADIPINE |
| Active Ingredient Strength | 5 mg/1 |
| Pharm Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 2006-01-05 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA077317 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-01-05 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| ISRADIPINE | 5 mg/1 |
| SPL SET ID: | e2f2b9a9-169f-4ccf-8974-58f21592c5bc |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 16252-539 | Isradipine | Isradipine |
| 16252-540 | Isradipine | Isradipine |
| 42806-263 | Isradipine | Isradipine |
| 42806-264 | Isradipine | Isradipine |
| 50268-454 | Isradipine | Isradipine |
| 50268-455 | Isradipine | Isradipine |
| 60429-385 | Isradipine | Isradipine |
| 60429-386 | Isradipine | Isradipine |
| 64850-910 | Isradipine | Isradipine |
| 64850-911 | Isradipine | Isradipine |
| 68151-1333 | Isradipine | Isradipine |
| 68462-807 | Isradipine | Isradipine |
| 68462-808 | Isradipine | Isradipine |